Activation of IL-6R with IL-6 treatment led to increased migration, as demonstrated by the scratch assay (Figure 2E and Figure S2F), and enhanced invasion, as shown by the spheroid assay (Figure 2F and Figure S2G), in both HPV-negative and HPV-positive HNSCC cells. Here, IL6 is linked to head and neck squamous cell carcinoma.